By Colin Kellaher
Revvity's board has authorized a new $1 billion share-repurchase program.
Revvity on Monday said the new buyback replaces the $1 billion repurchase program the Waltham, Mass., health-sciences company announced last October, which had $414.5 million remaining as of June 29.
Revvity, which had nearly 116.1 million shares outstanding as of Aug. 1, sports a market capitalization of roughly $11.5 billion.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 27, 2025 06:38 ET (10:38 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.